Louisiana 2021 Regular Session

Louisiana House Bill HB472

Introduced
4/2/21  
Introduced
4/2/21  
Refer
4/2/21  
Refer
4/2/21  

Caption

Provides relative to specialty licenses for the production of medical marijuana and the Jefferson Parish Economic Development Commission (OR INCREASE LF RV See Note)

Impact

If enacted, HB 472 would specifically modify state law regarding the licensing of therapeutic marijuana production facilities. Under the new framework, JEDCO's inclusion as a licensed entity reflects Louisiana's evolving stance on medical marijuana, aiming to broaden the opportunities for research and production within the state. The bill proposes to allow JEDCO to conduct research, either independently or through cooperative agreements with universities, schools of pharmacy, or licensed hospitals, and mandates annual reporting on research data and outcomes starting January 1, 2025.

Summary

House Bill 472 authorizes the Jefferson Parish Economic Development Commission (JEDCO) to be licensed as a production facility for therapeutic marijuana. This bill expands the existing framework that grants rights of first refusal for production facilities to the Louisiana State University Agricultural Center and Southern University Agricultural Center, thereby allowing JEDCO to participate in the production and research of therapeutic marijuana. The proposed legislation mandates that JEDCO notify the commissioner of agriculture of its intention to be licensed as a production facility and outlines the parameters surrounding production licensing and research responsibilities.

Sentiment

The overall sentiment regarding HB 472 appears positive among supporters who view it as a significant step in advancing medical marijuana research and production in Louisiana. Proponents argue that including JEDCO in this initiative could lead to more localized economic development and innovation within the therapeutic marijuana space. Nonetheless, there may be opposition from stakeholders who express concerns over the implications of expanding production facilities and the potential impacts on local communities and competition among existing entities.

Contention

Notable points of contention may arise regarding the balance of production rights and the equitable distribution of licenses. The right of first refusal granted to JEDCO alongside LSU and Southern University could potentially lead to conflicts of interest, especially if local governments or other entities feel their needs for therapeutic marijuana production are not adequately represented. Additionally, the bill's stipulations on reporting requirements might raise concerns about accountability and transparency in the research conducted by entities like JEDCO.

Companion Bills

No companion bills found.

Similar Bills

LA SB271

Provides for medical marijuana. (See Act) (RE1 SEE FISC NOTE GF EX See Note)

LA HB697

Reforms the state systems for regulating the production of marijuana for therapeutic use and for the dispensing of such product (EN INCREASE SG EX See Note)

LA SB35

Provides exemptions from arrest and prosecution to persons lawfully in possession of medical marijuana. (gov sig) (EN NO IMPACT GF EX See Note)

CA SB175

Developmental services: Canyon Springs Community Facility.

LA HR248

Urges and requests state entities that have a role in the implementation of Act No. 96 of the 2016 Regular Session relative to patient access to therapeutic marijuana to prioritize fully implementing the law as soon as possible

LA HB627

Authorizes the recommendation of medical marijuana for treating certain health conditions of persons with autism

LA HB566

Increases the number of entities eligible for licensure as medical marijuana production facilities (EG +$5,820,467 GF EX See Note)

LA HB1099

Provides relative to the assessment of a license fee imposed by the Department of Agriculture and Forestry for the production of marijuana for therapeutic use (EN SEE FISC NOTE GF EX See Note)